ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+12.73%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$225M
AUM Growth
-$5.82M
(-2.5%)
Cap. Flow
-$29.5M
Cap. Flow
% of AUM
-13.11%
Top 10 Holdings %
Top 10 Hldgs %
45.19%
Holding
92
New
27
Increased
21
Reduced
24
Closed
19
Top Buys
| 1 |
Sanofi
SNY
|
$5.95M |
| 2 |
WMGI
Wright Medical Group Inc
WMGI
|
$5.77M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$4.85M |
| 4 |
Bristol-Myers Squibb
BMY
|
$4.84M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$4.75M |
Top Sells
| 1 |
Abbott
ABT
|
$13M |
| 2 |
Merck
MRK
|
$12.6M |
| 3 |
Johnson & Johnson
JNJ
|
$7.76M |
| 4 |
Universal Health Services
UHS
|
$7.16M |
| 5 |
AGN
Allergan plc
AGN
|
$6.96M |
Sector Composition
| 1 | Healthcare | 92.74% |
| 2 | Industrials | 2.11% |
| 3 | Financials | 2.08% |
| 4 | Technology | 0.89% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gilead Sciences
GILD
$140B
| $796K | 0.35% |
10,315
-72,548
| -88% | -$5.6M |
|
|
ESRX
52
DELISTED
Express Scripts Holding Company
ESRX
| $789K | 0.35% |
8,305
-14,985
| -64% | -$1.42M |
|
|
VRAY
53
DELISTED
ViewRay, Inc.
VRAY
| $711K | 0.32% |
+75,971
| New | +$711K |
|
54
Acadia Pharmaceuticals
ACAD
$4.31B
| $672K | 0.3% |
+32,371
| New | +$672K |
|
55
Becton Dickinson
BDX
$54.4B
| $672K | 0.3% |
2,640
-14,648
| -85% | -$3.73M |
|
56
Orthofix Medical
OFIX
$585M
| $664K | 0.3% |
+11,478
| New | +$664K |
|
57
Edwards Lifesciences
EW
$47.7B
| $663K | 0.29% |
+11,418
| New | +$663K |
|
58
Liquidia Corp
LQDA
$2.45B
| $661K | 0.29% |
+24,085
| New | +$661K |
|
59
Jazz Pharmaceuticals
JAZZ
$7.82B
| $618K | 0.27% |
+3,674
| New | +$618K |
|
|
IMGN
60
DELISTED
Immunogen Inc
IMGN
| $607K | 0.27% |
64,065
-4,200
| -6% | -$39.8K |
|
61
Clearside Biomedical
CLSD
$26.7M
| $580K | 0.26% |
94,259
+64,859
| +221% | +$399K |
|
|
OMED
62
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $465K | 0.21% |
+219,114
| New | +$465K |
|
63
LivaNova
LIVN
$3.15B
| $459K | 0.2% |
+3,703
| New | +$459K |
|
|
SPPI
64
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $446K | 0.2% |
+26,534
| New | +$446K |
|
|
AKTX
65
Akari Therapeutics
AKTX
$22.5M
| $419K | 0.19% |
8,180
-835
| -9% | -$42.8K |
|
|
ARA
66
DELISTED
American Renal Associates Holdings, Inc
ARA
| $397K | 0.18% |
+18,340
| New | +$397K |
|
67
McKesson
MCK
$86.4B
| $374K | 0.17% |
2,822
-9,957
| -78% | -$1.32M |
|
|
68
Johnson & Johnson
JNJ
$429B
| $341K | 0.15% |
2,469
-56,158
| -96% | -$7.76M |
|
69
Axsome Therapeutics
AXSM
$6.1B
| $328K | 0.15% |
+95,185
| New | +$328K |
|
|
WBA
70
DELISTED
Walgreens Boots Alliance
WBA
| $261K | 0.12% |
3,581
-25,567
| -88% | -$1.86M |
|
71
Ocugen
OCGN
$319M
| $22K | 0.01% |
666
-270
| -29% | -$8.92K |
|
72
Centene
CNC
$14B
| – | – |
-35,222
| Closed | -$2.17M |
|
73
Cooper Companies
COO
$13.3B
| – | – |
-37,768
| Closed | -$2.22M |
|
74
Cencora
COR
$57.4B
| – | – |
-3,692
| Closed | -$315K |
|
75
HCA Healthcare
HCA
$96.9B
| – | – |
-30,755
| Closed | -$3.16M |
|